Mylan Gets Biogen MS Drug Patent Invalidated In W.Va. Court
A West Virginia federal judge on Thursday invalidated several claims of a Biogen patent covering its blockbuster multiple sclerosis drug Tecfidera after finding the company wrongly worked a new invention into...To view the full article, register now.
Already a subscriber? Click here to view full article